VASOPRESSIN FOR TBI:  FROM BENCHTOP TO BEDSIDE

Kenneth Proctor

At the conclusion of this presentation, attendees will be able to:

1. Identify the structure and actions of endogenous anti-diuretic hormone (arginine vasopressin)
2. Outline FDA approved indications for vasopressin
3. Describe Pre-clinical Data supporting the use of vasopressin in the initial resuscitation of trauma patients 
4. Describe initial clinical Data supporting the use of vasopressin for CPP management in TBI patients